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Background: Proximal aortic control by endovascular balloon occlusion (EBO) is an alternative to conventional aortic
cross-clamping (CAC) in hemodynamically unstable patients presenting with a ruptured abdominal aortic aneurysm
(rAAA). The aim of this study was to evaluate the potential clinical beneﬁt of EBO over CAC.
Methods:Data from 72 patients with rAAA treated at our institution from 2001 to 2013 were retrospectively analyzed. All
patients were hemodynamically unstable (mean arterial blood pressure at admission <65 mm Hg or associated uncon-
sciousness, cardiac arrest, or emergency endotracheal intubation). Clinical end points of hemodynamic restoration,
mortality rate, and major postoperative complications were assessed for CAC (group 1) and EBO (group 2).
Results: At admission, 72 patients were unstable. CAC was performed in 40 and EBO in 32. Intraoperative mortality was
43% in group 1 vs 19% in group 2 (P[ .031). In group 1, the approach for CAC (thoracotomy [n[ 23] vs laparotomy
[n[ 17]) did not inﬂuence intraoperative mortality (43% vs 41%). There was no signiﬁcant difference in 30-day (75% vs
62%) and in-hospital (77% vs 69%) mortality rates between groups. After EBO, the treatmentdopen vs endovascular
repairddid not inﬂuence the intraoperative mortality rate (31% vs 43%; P [ .5). Eight surgical complications were
secondary to CAC (1 vena cava injury, 3 left renal vein injuries, 1 left renal artery injury, 1 pancreaticoduodenal vein
injury, and 2 splenectomies), but no EBO-related complication was noted (P[ .04). Differences in colon ischemia (15%
vs 28%) and renal failure (12% vs 9%) were not statistically signiﬁcant. Abdominal compartment syndrome occurred in
four patients in group 2 and in no patients in group 1.
Conclusions: Compared with CAC, EBO is a feasible and valuable strategy and is associated with reduced intraoperative
mortality of unstable rAAA patients, but not in-hospital mortality, in this retrospective study. (J Vasc Surg
2015;61:304-8.)Proximal aortic control remains one of the challenges
of the management of unstable patients with ruptured
abdominal aortic aneurysms (rAAAs). Patients are usually
treated by performing an expeditious midline incision
with control of the infrarenal or upper abdominal aorta
by direct aortic cross-clamping. Clamping of the descend-
ing thoracic aorta through a left thoracotomy is an alterna-
tive technique in unstable patients with previous upper
abdominal surgery or an intraperitoneal rupture. These
techniques require emergency general anesthesia, with a
high risk of cardiac arrest. Perioperative mortality remains
high (32%-80%) and has not improved signiﬁcantly during
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://dx.doi.org/10.1016/j.jvs.2014.07.098Proximal aortic control of an rAAA by endovascular
balloon occlusion (EBO) was ﬁrst described through a
brachial approach by Heimbecker5 in 1964. Transaxillary
EBO was proposed by Smith6 in 1972. More recently,
percutaneous EBO has been proposed through a brachial7
or a femoral8 approach. Advantages of EBO over conven-
tional techniques include ability to perform the technique
under local anesthesia, speed and effectiveness in achieving
hemodynamic stability, and use with conventional open or
endovascular repair.9 The aim our study was to determine
the beneﬁt of EBO over conventional aortic cross-clamping
(CAC) in hemodynamically unstable rAAA patients
secondarily receiving endovascular aortic repair (EVAR)
or open surgical repair (OSR).
METHODS
Consecutive rAAA patients treated in our Vascular Sur-
gery Unit from January 2001 to December 2013 were
retrospectively reviewed from a prospective database. The
Institutional Review Board approved the study, and waived
patient consent for this retrospective record review.
We only collected data of hemodynamically unstable
patients with at least one of the following criteria: mean
blood pressure (MBP), calculated as [(systolic pressure þ
{2  diastolic pressure})/3] upon admission of <65 mm Hg,
Fig. Evolution of our practice from 2001 to 2013. Endovascular
balloon occlusion (EBO) was ﬁrst used in 2002. A speciﬁc
“endoclamping” kit has been available since 2007. CAC, Con-
ventional aortic cross-clamping.
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endotracheal intubation. Patients deemed unﬁt for surgi-
cal intervention or who were hemodynamically stable (sta-
ble MBP >65 mm Hg) after initial ﬂuid resuscitation
using <500 mL/30 min intravenous crystalloid ﬂuid
load were excluded. Patients referred for thoracoabdomi-
nal aneurysms were also excluded.
Patients were allocated to two groups according to the
technique of aortic control: CAC, followed by OSR (group
1), or EBO, followed by OSR or EVAR, depending on
anatomic criteria and feasibility (group 2).
EBO was initially attempted through a percuta-
neous femoral approach using a speciﬁc kit including
an introducer sheath 9F (Terumo, Heverlee, Belgium),
a 0.035-inch heavy-duty guidewire (Terumo), a 5F Van
Schie catheter (Cook Medical, Bloomington, Ind), a
260-cm-long extra-stiff Lunderquist guidewire (Cook
Medical), a 45-cm-long 14F sheath (Cook Medical),
and a 46-mm-diameter reliant aortic balloon (Med-
tronic, Brussels, Belgium).
If the percutaneous approach failed, we performed a
femoral cutdown under local anesthesia (0.5% bupivacaine)
and puncture of the common femoral artery under direct
vision. A 0.035-inch heavy-duty guidewire (Terumo) was
inserted under ﬂuoroscopic guidance (OEC 9800;
GE-OEC Medical Systems, Salt Lake City, Utah), up to
the level of the descending aorta, and then exchanged for
an extra-stiff guidewire. A 14F sheath was inserted over
the guidewire up to the level of the celiac axis, allowing
placement of the aortic balloon. The balloon was inﬂated
proximal to the rAAA, at the level of the distal descending
thoracic aorta, just above the diaphragmatic crus. The
sheath was advanced so that it abutted the inﬂated balloon
and was secured to patient’s skin at the groin to prevent
distal migration. A pigtail catheter was inserted through
the contralateral femoral artery to just below the occlusion
balloon, allowing an angiogram to assess the feasibility of
EVAR treatment.
EVAR was performed whenever feasible (aortic neck
$15 mm, angulation <90, neck diameter <32 mm,
adequate iliac sealing zone, good iliac access). The main
body of the stent graft was inserted through the contralat-
eral approach. In this case, lateral puncture with a 5F
sheath of the valve of the ipsilateral 14F sheath allowed
insertion of a pigtail up to the aneurysm neck to monitor
the procedure. When hemodynamic stability was achieved,
the EBO was deﬂated and withdrawn from the aneurysm
sac to allow successful stent graft deployment.
In case of persisting hemodynamic instability, the
balloon was kept inﬂated during graft deployment,
providing that the distal end of the sheath supporting the
balloon was above the proximal edge of the stent graft,
to allow balloon retrieval through the sheath once the stent
graft had been deployed. Alternatively, in case of recurring
hemodynamic instability after occlusion balloon retrieval,
the occlusion balloon could be inserted again through
main body of the stent graft and inﬂated to restore hemo-
dynamic stability.When EVAR was not deemed feasible, the balloon was
kept inﬂated to avoid hemodynamic variations during anes-
thesia and the ﬁrst steps of OSR until aortic control allowed
proximal cross-clamping.
Clinical outcomes. The main outcome variable was
restoration of hemodynamic stability deﬁned by stable
MBP >65 mm Hg associated with a reduction of $50%
of vasopressive drugs mass ﬂow. Secondary outcomes
were intraoperative, 30-day, and in-hospital mortality
rates, and morbidity directly related to EBO or CAC.
Statistical analysis. Nonparametric continuous vari-
ables are described using means and minimum and
maximum values and were compared using a Mann-
Whitney test. Categoric variables are described using
numbers and percentages and were compared using c2 or
Fisher exact tests. Continuous values are given as mean
with the standard deviation or range. P <.05 was consid-
ered signiﬁcant.
RESULTS
Over 13 years, 159 consecutive patients (mean age,
75 years; range, 49-96 years) presenting with an rAAA un-
derwent operations in our institution. Initial hemodynamic
instability was present in 72 patients, who were analyzed in
this study. In early 2001, we only performed CAC, and our
experience with EBO started in 2002. The Fig shows the
evolution of our practice over time.
We performed CAC (group 1) in 40 of the 72 patients,
using a thoracotomy in 23 and laparotomy in 17. Cross-
clamping in these 17 patients was infrarenal in 12 and
suprarenal in ﬁve. EBO (group 2) was performed in 32 pa-
tients, followed by OSR (n ¼ 24) or EVAR (n ¼ 8; one
died before graft insertion). The proportion of complex
AAAs (aneurysm without infrarenal neck or clamp site,
with renal or visceral arteries involvement) was identical
in both groups (15% in group 1 vs 12% in group 2; P ¼
1). The mean time for proper balloon placement was
9 minutes (range, 5-13 minutes) after arrival in the oper-
ating room. Unfortunately, the time taken to achieve aortic
Table I. Intraoperative, 30-day, and in-hospital
mortality rates in unstable patients operated on for
ruptured abdominal aortic aneurysms (rAAAs)
Variable No.
Mortality
Intraoperative,
No. (%)
30-day,
No. (%)
In-hospital,
No. (%)
CAC
Overall 40
Thoracotomy 23 10 (43) 17 (74) 17 (74)
Laparotomy 17 7 (41) 13 (76) 14 (82)
Stabilized 23 0 13 (56) 14 (61)
EBO
Overall 32 6 (19) 20 (62) 22 (69)
Stabilized 26 0 14 (54) 16 (61)
Treatment
OSR 65 20 (31) 47 (72) 50 (77)
EVAR 7 3 (43) 3 (43) 3 (43)
Total 72 23 (32) 50 (69) 53 (74)
CAC, Conventional aortic cross-clamping; EBO, endovascular balloon
occlusion; EVAR, endovascular aortic repair; OSR, open surgical repair.
Table II. Mortality and complications of conventional
aortic cross-clamping (CAC) vs endovascular balloon
occlusion (EBO) in 72 unstable patients
Variable
CAC
(n ¼ 40),
No. (%)
EBO
(n ¼ 32),
No. (%) P
Intraoperative mortality 17 (43) 6 (19) .031
OSR (n ¼ 65) 17 (43) 13 (41) .57
EVAR (n ¼ 7) 0 3 (e) e
Complications
Colonic ischemia 6 (15) 9 (28) .17
Renal failure 5 (12) 3 (9) .67
Compartment syndrome 0 4 (12) e
30-day mortality 30 (75) 20 (62) .25
In-hospital mortality 31 (77) 22 (69) .40
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recorded in most patients.
Regaining intraoperative hemodynamic stability, as
deﬁned by criteria detailed above, was achieved in only
57% of group 1 patients vs 85% of group 2 patients (P ¼
.014). Intraoperative mortality was 43% in group 1 and
19% in group 2 (P ¼ .031). Table I summarizes the intra-
operative, 30-day, and in-hospital mortality rates of the 72
unstable patients. There was no signiﬁcant difference in the
total 30-day (75% vs 62%; P ¼ .25) and in-hospital (77% vs
69%; P ¼ .40) mortality rates between groups. An analysis
of the patient subgroup that regained hemodynamic stabil-
ity found no signiﬁcant difference in 30-day (56% in group
1 vs 54% for group 2; P ¼ .85) and in-hospital mortality
(61% vs 62%; P ¼ .96). Furthermore, we compared 30-
day mortality between two periodsd2001 and 2006
(only one EBO case) and between 2007 and 2013dand
found no signiﬁcant difference (67% vs 70%; P ¼ .81).
The rate of colonic ischemia and of acute renal failure
was not signiﬁcantly different between groups 1 and 2
(15% and 12% vs 28% and 9%, respectively). In group 2,
seven patients had EVAR and 25 had OSR. Among
them, colonic ischemia occurred in one in the rEVAR
group and in eight in the OSR group (32%; P ¼ .64).
Although not signiﬁcant, there is a trend in favor of rEVAR
to reduce colonic ischemia. In group 1, there was no signif-
icant difference between those with thoracic and abdom-
inal cross-clamping in these secondary outcomes or in
intraoperative mortality (43% vs 41%; P ¼ .894). In group
2, postoperative compartment syndrome developed in four
patients that required decompressive laparotomy. These
data are summarized in Table II.
In group 1, eight patients sustained an injury as a direct
result of aortic cross-clamping: 1 vena cava injury, 3 left renal
vein injuries, 1 left renal artery injury, 1 pancreaticoduodenal
vein injury, and 2 splenectomies. All complications were
immediately treated, and there was no negative effect on pa-
tient outcome. In group 2, there were no complications
related to EBO (P ¼ .04). In particular, there were no car-
diac complications related to balloon inﬂation, and the
only death before treatment was related to a hypovolemic
cardiac arrest that occurred despite all resuscitation maneu-
vers, including successful aortic occlusion.
DISCUSSION
The beneﬁt of EBO over CAC has been suggested by
several recent publications,10,11 claimed by animal experi-
mentation,12 but never established by a comparative study.
To our knowledge, this report is the ﬁrst to compare both
techniques. Patients in this series were not randomized to
EBO or CAC treatment. Management was left to the sur-
geon’s discretion. Moreover the strategy has evolved over
time. The skill of the surgeons has certainly affected the
choice of the treatment: less experienced vascular surgeons
were initially more likely to use EBO as the primary proce-
dure for hemodynamic stabilization compared with skilled
physicians comfortable with CAC. These limitations
may have affected our comparative outcome variables.However, given the intuitive superiority of EBO over
CAC, obtaining an ethical approval for a randomized trial
would have been impossible.
In the present analysis, we observed that EBO was
feasible in rAAA patients. We have shown that EBO
restored hemodynamic stability in 85% of patients. Of
utmost importance, we have demonstrated that EBO,
compared with CAC, signiﬁcantly reduced intraoperative
mortality of rAAA patients. Despite a trend of improved
survival for patients treated with EBO and receiving
EVAR, we failed to demonstrate that EBO affected 30-
day and in-hospital mortality rates. The small size of the
cohort could account for these conclusions, and probably,
conclusions would have been different with a larger cohort.
Unfortunately, we could not evaluate the effect of both the
level and the type of aortic occlusion on the secondary
outcome variables we have monitored.
In our series, we report a relatively high proportion
(45%) of unstable patients admitted with rAAA. This may
be due to the French national care system for two reasons:
JOURNAL OF VASCULAR SURGERY
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secondary care hospitals with no on-site vascular
units. Transfer to a specialized vascular unit accounts
for delays in treatment.
2. France has not adopted a “scope and run policy”
but rather a “stay and treat” policy, which is dele-
terious in some patients who require rescue
surgery. Usually, the PHEMD (Pre-Hospital
Emergency Medicine Department) uses an ambu-
lance equipped for resuscitation at patient’s home,
with a medical team comprising an intensive care
medicine physician and a specialized nurse. This
medical team starts on-the-scene initial ﬂuid resus-
citation, inotropic, and respiratory support,
attempting to improve hemodynamics before trans-
fer to the tertiary care hospital. This management,
which combines diagnosis and treatment, favors
optimal triage strategy and may improve the
outcome in situations such as acute coronary syn-
dromes but may delay referral of surgical emergen-
cies such as rAAA.
We performed the ﬁrst EBO case in 2002. EBO was
not always feasible due to lack of availability of an endovas-
cular suite or permanent staff skilled in endovascular inter-
ventions, or both. Owing these factors, no EBO was
performed between 2002 and 2007. But in 2007, our
team designed a disposable “endoclamping kit,” usable
by all surgeons, resulting in an increase in EBO use and a
reduction of primary CAC in unstable rAAA patients
(Table I). Today, all vascular surgeons managing rAAA
use ﬁrst-line EBO in unstable patients because of its
simplicity of placement and efﬁciency at restoring hemody-
namic stability.13
Another major advantage of EBO over CAC relies on
the fact that the balloon can be positioned under local
anesthesia, thus sparing the patient’s abdominal muscles
tone. Induction of anesthesia required for CAC intensively
reduces abdominal pressure, which is reputed to prevent
blood loss. Moreover, the dramatic anesthetic agent-
induced decrease in systemic vascular resistance worsens
tissue perfusion, thus compromising already altered organ
function. Of interest, general anesthesia can be more safely
induced after hemodynamics have been restored by aortic
occlusion performed under local anesthesia.14,15 Moreover,
EBO allows a rapid increase of cerebral and coronary perfu-
sion, while decreasing hemorrhage and blood loss due to
open repair.6
Nevertheless, our report presents several limitations. Its
retrospective nature and the small size of our cohort are the
most important. Furthermore, the learning curve of EBO
and above all rEVAR may have affected on our results.
The proportion of unstable rAAAs treated by EVAR is
low (10%) compared with the number of EVARs per-
formed on the entire series of rAAAs (34%). Young sur-
geons are not always comfortable with emergency EVAR,
especially for unstable patients, which could explain why
we report only seven rEVARs in our study.Lastly, because these patients arrive in an extreme
emergency context and are usually directly transferred
to the operating room, recording of previous medical
history and comorbidities is sometimes impossible. For
this reason, it is possible that our two groups might not
have been exactly identical in clinical characteristics and
comorbidities.
Some authors have dismissed the use of EBO, stating
that rapid placement of a stent graft is just as effective.
This may be true in hemodynamically stable rAAAs, but
even in highly specialized units, EVAR cannot challenge
the 9-minute mean time it takes to perform EBO. EBO
is particularly useful for less experienced surgeons who
may not have the experience to make rapid intraoperative
decisions. EBO is also advantageous in the patient with
hostile anatomy who may not be suitable for an endovascu-
lar intervention. Furthermore, EBO allows “anesthetic
catch up” and patient stabilization after balloon inﬂation
before the deﬁnitive surgical procedure is performed.
If OSR is chosen after EBO, endovascular occlusion of
the aorta has the potential beneﬁts to enable careful dissec-
tion, avoids massive bleeding, and decreases the risk of
damaging neighboring fragile anatomic structures. Because
EBO allows EVAR of the rAAA, hemodynamic instability
should no longer be a contraindication for EVAR. Only
anatomic criteria should be taken into account. Even in
the absence of a preoperative computed tomography
scan,10,13 an intraoperative angiogram can be achieved
through the sheath used for EBO or by a contralateral
pigtail.
Although a brachial7 or axillary6 approaches are
feasible, we favored the femoral route for several reasons:
(1) a left brachial approach interferes with the positioning
of the C-arm, as a contralateral right side approach carries
a risk of cerebral emboli14; (2) for both sides, the risk of pe-
ripheral emboli from the aortic arch or the descending
aorta is higher than with the femoral approach7; (3)
currently available EBO catheters require 10F to 14F intro-
ducer sheaths, which may damage the brachial artery or
require an axillary cutdown. Among complications of
EBO, ruptures of occlusion balloon have occasionally
been reported,7,16 but we did not experience such an event
in our patients, probably because we use a dedicated
inﬂator to monitor the inﬂation pressure.
Despite many technical advances, mortality for these
patients remains high and not only linked to aortic repair
modalities. The patient’s medical history and clinical condi-
tion at arrival are crucial, with a direct effect on mortality.
Although a recent randomized trial did not show a signif-
icant effect of the technique (EVAR vs OSR) on 30-day
mortality17 of rAAA, an increasing number of surgeons
seem convinced that EVAR is more effective than OSR.18
EBO, while restoring hemodynamic stability, increases
the proportion of patients eligible for EVAR.
CONCLUSIONS
In this retrospective series, EBO of the aorta in unsta-
ble rAAAs compared with CAC may be associated with a
JOURNAL OF VASCULAR SURGERY
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collateral damage, such as surgical injuries, although it
did not signiﬁcantly inﬂuence in-hospital mortality. EBO,
while restoring hemodynamic variables, could facilitate
EVAR in unstable rAAA but does not preclude OSR.
Further studies with larger cohorts are mandatory to eval-
uate beneﬁts of EBO over CAC.
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